Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $135.20 and traded as high as $152.85. Hoya shares last traded at $151.82, with a volume of 87,647 shares trading hands.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on HOCPY. The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Nomura Securities upgraded shares of Hoya to a "strong-buy" rating in a research report on Monday, August 18th. Three research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, Hoya has an average rating of "Strong Buy".
Get Our Latest Analysis on Hoya
Hoya Price Performance
The company's fifty day moving average is $135.20 and its 200 day moving average is $123.70. The firm has a market cap of $52.09 billion, a price-to-earnings ratio of 37.96, a PEG ratio of 3.12 and a beta of 1.03. The company has a quick ratio of 4.46, a current ratio of 5.19 and a debt-to-equity ratio of 0.03.
Hoya (OTCMKTS:HOCPY - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.01. Hoya had a net margin of 23.57% and a return on equity of 21.01%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.47 billion. On average, equities research analysts predict that Hoya Corp. will post 3.66 EPS for the current year.
About Hoya
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.